Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

2001 Vaccine Research Seminars

Future Seminars | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Seminars are held on the NIH campus in Building 40, Conference Rooms 1201 & 1203, on Tuesdays at 4:00 PM (except as noted).





Dec. 19, 2001 Rafi Ahmed Emory University Immunological Memory: Lessons for vaccine development PLEASE Note: This talk will be in the Masur Auditorium (Building 10) as part of WALS (Wednesday)
Dec. 14, 2001 Jaap Goudsmit   Vaccines that do not prevent HIV infection: the technical challenges, the individual consequences and the population effect.
Dec. 11, 2001 Marjorie Robert-Guroff NCI Immunogenicity and protective efficacy of adenovirus-recombinant vaccines for AIDS
Nov. 20, 2001 David Weiner University of Pennsylvania Improvements and complications of multicomponent DNA vaccines for HIV-1
Nov. 13, 2001 Harriet Robinson Yerkes Primate Center and Emory University Working towards an AIDS Vaccine
Nov. 6, 2001 Steve Hoffman Celera, Inc. From Genomics to Proteomics to Vaccine: A 21st Century Challenge
Oct. 30, 2001 Hana Golding CBER/FDA Dissection of HIV-1 entry mechanism by neutralizing antibodies to gp41 fusion intermediate structures
Oct. 23, 2001 Francine McCutchan, Ph.D. Henry M. Jackson Foundation HIV Recombination and Vaccine Development
Oct. 16, 2001 Jeff Lifson NCI/Frederick Monkey Tales: Insights into AIDS Virus pathogenesis from studies of non-human primates
Oct. 9, 2001 James Hoxie University of Pennsylvania Structure/Function studies of CD4-independent HIV envelope glycoproteins
Sept. 25, 2001 Barney Graham, M.D., Ph.D. Vaccine Research Center Pathogenesis of respiratory syncytial virus: Implications for vaccine development
June 19, 2001 Bernard Moss, M.D., Ph.D. NIAID Molecular and Cellular Biology of Vaccinia Virus: Implications for use as a Vaccine Vector
June 12, 2001 Robinson James, M.D. Tulane University Health Sciences Center Antibodies Recognizing CD4-induced Epitopes of HIV-1 gp120
June 5, 2001 Larry Arthur, Ph.D. NCI Inactivated virions; use as immunogens in vaccines and as in vitro reagents
May 29, 2001 Stephen E. Straus, M.D. NCCAM Development and testing of vaccines for genital herpes
May 22, 2001 Jay Berzofsky, M.D. NIH/NCI Approaches to design improved engineered vaccines for HIV
May 15, 2001 Joseph Sodroski, M.D. Department of Pathology, Harvard Immune evasion by HIV-1
May 8, 2001 Larry Corey Fred Hutchinson Cancer Research Center Comparative trials of new vaccines: What happens after the initial results?
Apr. 24, 2001 Anthony Fauci, M.D. NIAID Host factors in HIV disease: Implications for therapeutic strategies
Apr. 17, 2001 John Moore, Ph.D. Cornell University Studies on HIV-1 envelope glycoprotein vaccine antigens and entry inhibitors
Apr. 10, 2001 George Lewis, PH.D. Institute of Human Virology Form and function of anti-viral beta-chemokines synthesized by diverse T cell subsets
Mar. 20, 2001 Malcolm Martin, M.D. Molecular Microbiology, NIAID The use of highly pathogenic SIV/HIV chimeric viruses for studies of immunodeficiency
Mar. 13, 2001 Dana H. Gabuzda, M.D. Dana-Farber Cancer Institute Role of HIV-1 envelope glycoproteins in neurotropism and viral pathogenesis
Feb. 27, 2001 William Paul, M.D. Laboratory of Immunology, NIAID Allelic bias in IL-4 expression: Mechanisms and significance
Feb. 20, 2001 Dennis R. Burton, Ph.D. Scripps Research Institute The anti-viral activities of antibodies in vitro and in vivo: rules and mechanisms
Feb. 13, 2001 Edward Berger, Ph.D. Laboratory of Viral Diseases, NIAID HIV Env/Receptor Interactions: Mechanisms and Opportunities
Jan. 30, 2001 Norman Letvin, M.D. Beth Israel Deaconess Medical Center Vaccine-induced CTL & control of AIDS Virus replication
Jan. 23, 2001 Gary Nabel, M.D., Ph.D. Vaccine Research Center, NIAID Progress and Challenges for AIDS Vaccine Development

View Past Seminars

back to top

Last Updated January 25, 2012